Please enable Javascript to use all features and improve your user experience.
ECV 2023
Programme
People
Search
DE
Back
Session
Session 20
Vaccines II
Appointment
Date:
6th May 2023
Time:
04:00 p.m.
–
05:45 p.m.
Location / Stream:
Sala Koncertowa
Chair
Albert Osterhaus
Hannover / DE
Programme
04:00 p.m.
–
04:15 p.m.
10 Min.
5 Min.
Abstract Talk
AT 18
Structural studies of dengue virus antibody/antigen complexes
Professor Félix A. Rey (Paris / FR)
Vaccines
04:15 p.m.
–
04:30 p.m.
10 Min.
5 Min.
Abstract Talk
AT 53
Stalk antibody-mediated broad protection against influenza viruses
Dr. Nisreen Okba (New York, NY / US)
Vaccines
04:30 p.m.
–
04:45 p.m.
10 Min.
5 Min.
Abstract Talk
AT 54
Development of an economically viable vaccine for CCHF virus
Dr. Mine Aksular (Oxford / GB)
Immune response to virus infection, Vaccines
04:45 p.m.
–
05:00 p.m.
10 Min.
5 Min.
Abstract Talk
AT 55
Low energy electron irradiation efficiently inactivates various viruses in liquids for vaccine production processes
Dr. Jasmin Fertey (Leipzig / DE)
Vaccines
05:00 p.m.
–
05:15 p.m.
10 Min.
5 Min.
Abstract Talk
AT 56
A novel SARS-CoV-2 modified live vaccine with an optimized safety profile induces sterile immunity in Syrian hamsters
Dr. Jacob Schön (Greifswald – Insel Riems / DE)
SARS -CoV2 and other coronaviruses, Vaccines
05:15 p.m.
–
05:30 p.m.
10 Min.
5 Min.
Abstract Talk
AT 57
Virus-like particle vaccine production in insect cells without contaminating baculovirus particles
Linda van Oosten (Wageningen / NL)
Invertebrate viruses, Vaccines
05:30 p.m.
–
05:45 p.m.
10 Min.
5 Min.
Abstract Talk
AT 58
Developing live attenuated vaccines for SARS-CoV-2
Professor Dong-Yan Jin (Pokfulam / HK)
Vaccines
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy